These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16793840)

  • 61. Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis.
    Wolbink GJ; Vis M; Lems W; Voskuyl AE; de Groot E; Nurmohamed MT; Stapel S; Tak PP; Aarden L; Dijkmans B
    Arthritis Rheum; 2006 Mar; 54(3):711-5. PubMed ID: 16508927
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Non-response to infliximab may be due to innate neutralizing anti-tumour necrosis factor-alpha antibodies.
    Ebert EC; Das KM; Mehta V; Rezac C
    Clin Exp Immunol; 2008 Dec; 154(3):325-31. PubMed ID: 18826498
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Infliximab treatment reduces the serum levels of interleukin-23 in patients with rheumatoid arthritis.
    Kageyama Y; Kobayashi H; Kato N
    Mod Rheumatol; 2009; 19(6):657-62. PubMed ID: 19685204
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy.
    De Rycke L; Kruithof E; Van Damme N; Hoffman IE; Van den Bossche N; Van den Bosch F; Veys EM; De Keyser F
    Arthritis Rheum; 2003 Apr; 48(4):1015-23. PubMed ID: 12687543
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The value of rheumatoid factor and anti-citrullinated protein antibodies as predictors of response to infliximab in rheumatoid arthritis: an exploratory study.
    Klaasen R; Cantaert T; Wijbrandts CA; Teitsma C; Gerlag DM; Out TA; de Nooijer MJ; Baeten D; Tak PP
    Rheumatology (Oxford); 2011 Aug; 50(8):1487-93. PubMed ID: 21454308
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Anti-infliximab antibodies are already detectable in most patients with rheumatoid arthritis halfway through an infusion cycle: an open-label pharmacokinetic cohort study.
    van den Bemt BJ; den Broeder AA; Wolbink GJ; Hekster YA; van Riel PL; Benraad B; van den Hoogen FH
    BMC Musculoskelet Disord; 2011 Jan; 12():12. PubMed ID: 21232150
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Serum trough infliximab and anti-infliximab antibodies in a cohort of gastroenterology and rheumatology patients' infliximab therapeutic drug monitoring.
    Barlow NL; Mohammed P; Berg JD
    Ann Clin Biochem; 2016 Jul; 53(Pt 4):477-84. PubMed ID: 26290514
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Apolipoprotein A-I and platelet factor 4 are biomarkers for infliximab response in rheumatoid arthritis.
    Trocmé C; Marotte H; Baillet A; Pallot-Prades B; Garin J; Grange L; Miossec P; Tebib J; Berger F; Nissen MJ; Juvin R; Morel F; Gaudin P
    Ann Rheum Dis; 2009 Aug; 68(8):1328-33. PubMed ID: 18664547
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Increased Induction Infliximab Clearance Predicts Early Antidrug Antibody Detection.
    Eser A; Reinisch W; Schreiber S; Ahmad T; Boulos S; Mould DR
    J Clin Pharmacol; 2021 Feb; 61(2):224-233. PubMed ID: 32905628
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The effects of infliximab therapy on the serum proteome of rheumatoid arthritis patients.
    Dwivedi RC; Dhindsa N; Krokhin OV; Cortens J; Wilkins JA; El-Gabalawy HS
    Arthritis Res Ther; 2009; 11(2):R32. PubMed ID: 19265537
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Restricted immune activation and internalisation of anti-idiotype complexes between drug and antidrug antibodies.
    van Schie KA; Kruithof S; Ooijevaar-de Heer P; Derksen NIL; van de Bovenkamp FS; Saris A; Vidarsson G; Bentlage AEH; Jiskoot W; Romeijn S; Koning RI; Bos E; Stork EM; Koeleman CAM; Wuhrer M; Wolbink G; Rispens T
    Ann Rheum Dis; 2018 Oct; 77(10):1471-1479. PubMed ID: 29945923
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The Immunogenicity of Branded and Biosimilar Infliximab in Rheumatoid Arthritis According to Th9-Related Responses.
    Talotta R; Berzi A; Doria A; Batticciotto A; Ditto MC; Atzeni F; Sarzi-Puttini P; Trabattoni D
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29023386
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Role of scintigraphy with ⁹⁹mTc-infliximab in predicting the response of intraarticular infliximab treatment in patients with refractory monoarthritis.
    Conti F; Malviya G; Ceccarelli F; Priori R; Iagnocco A; Valesini G; Signore A
    Eur J Nucl Med Mol Imaging; 2012 Aug; 39(8):1339-47. PubMed ID: 22588625
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Successful treatment of refractory mononeuritis multiplex secondary to rheumatoid arthritis with the anti-tumour necrosis factor alpha monoclonal antibody infliximab.
    Garcia-Porrua C; González-Gay MA
    Rheumatology (Oxford); 2002 Feb; 41(2):234-5. PubMed ID: 11886980
    [No Abstract]   [Full Text] [Related]  

  • 75. Infliximab concentration monitoring improves the control of disease activity in rheumatoid arthritis.
    Mulleman D; Méric JC; Paintaud G; Ducourau E; Magdelaine-Beuzelin C; Valat JP; Goupille P;
    Arthritis Res Ther; 2009; 11(6):R178. PubMed ID: 19939280
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Clinical images: infliximab therapy of polyarticular small joint sarcoid arthritis.
    Huang A; Harty LC; Ryan CM; Veale DJ
    Arthritis Rheum; 2011 Jul; 63(7):2030. PubMed ID: 21425127
    [No Abstract]   [Full Text] [Related]  

  • 77. Scintigraphic detection of tumour necrosis factor in patients with rheumatoid arthritis.
    Barrera P; Oyen WJ; Boerman OC; van Riel PL
    Ann Rheum Dis; 2003 Sep; 62(9):825-8. PubMed ID: 12922953
    [TBL] [Abstract][Full Text] [Related]  

  • 78. (18) F-FDG PET imaging of rheumatoid articular and extraarticular synovitis.
    Fonseca A; Wagner J; Yamaga LI; Osawa A; da Cunha ML; Scheinberg M
    J Clin Rheumatol; 2008 Oct; 14(5):307. PubMed ID: 18838912
    [No Abstract]   [Full Text] [Related]  

  • 79. [The use of ultrasound to assess the extent of inflammation in rheumatoid arthritis].
    Hammer HB
    Ultraschall Med; 2010 Aug; 31(4):437-8. PubMed ID: 20725899
    [No Abstract]   [Full Text] [Related]  

  • 80. The New Test for Monitoring Infliximab Therapy: From Laboratory to Clinical Practice.
    De Santis E; Melegari A; Bonaguri C; Sandri G; Mascia MT; Gaiani F; Pecoraro V; De Angelis G; Trenti T
    Isr Med Assoc J; 2018 Feb; 20(2):91-94. PubMed ID: 29431302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.